Nicholas Vardy
Booking 107% profits in Spreadtrum Communications (SPRD)
With the market up sharply this morning on the relief rally driven by Europe’s debt deal, your Spreadtrum Communications (SPRD) call options have soared, as well. You’ve already sold half of your SPRD options for 61% gains. I’m now recommending that you sell your remaining SPRD options to book a 107% gain. That profit makes […]
The Market Finally Breaks out
After being locked in a trading range reaching back to early August, the S&P 500 Index finally broke through the 1,230 resistance level. That said, the U.S. market pulled back to just that level yesterday, ending the week up only slightly. The MSCI Emerging Markets Index fared only a bit better on the week. We […]
Betting on the Budweiser of Latin America — and Taking 61.29% Gains in Spreadtrum Options
As often happens in Q4, global financial markets have regained their mojo. The Dow gained 1.4%, scoring its fourth straight up week and the S&P 500 added 1.1% for its third up week in a row. The S&P 500 broke through an area of prior resistance around 1,230 and closed last Friday at its highest […]
Off to the Races?
Judging by the market action over the last two weeks, you might get the idea that all is right in the world and that the markets are “off to the races” for a traditional Q4 rally. Since testing the all-mighty, 1,100 support level yet again, the S&P 500 Index has rallied for two straight weeks. […]
A Surprising Safe Have… “Down on the Farm”
It was a big week for the stock market last week, with the Nasdaq shooting up 7.6% — its best gain since a 10.6% gain in the week ended March 13, 2009. The S&P 500 climbed 6% and the Dow Jones industrial average jumped 4.9%. The S&P has now enjoyed a 10% rally over the […]
Betting on Bounce in Biotech
As we enter the start of earnings season, it’s time to up your bets on stocks going into what traditionally has been the strongest quarter for the stock market. Among the fast-growing major biotechs announcing earnings in the coming weeks is this week’s Bull Market Alert recommendation, Connecticut-based Alexion Pharmaceuticals (ALXN). I first recommended this […]